CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial Determinants of exercise intolerance in heart failure with preserved ejection fraction: A systematic review and meta-analysis Design of a bilevel clinical trial targeting adherence in heart failure patients and their providers: The Congestive Heart Failure Adherence Redesign Trial (CHART) Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure The year in cardiovascular medicine 2020: heart failure and cardiomyopathies Good response to tolvaptan shortens hospitalization in patients with congestive heart failure

Original Research2017 Apr; 6(4): e003330.

JOURNAL:J Am Heart Assoc. Article Link

Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction

Goyal P, Paul T, Almarzooq ZI et al. Keywords: epidemiology; heart failure; mortality

FULL TEXT PDF